Center for Human Reproduction

The Center for Human Reproduction (CHR) is a prominent fertility center in the U.S., established in 1981 and based in New York City. It has gained national and international recognition as the infertility center of last resort, particularly for patients who have experienced multiple failed IVF cycles. CHR specializes in treating diminished ovarian reserve, a common issue in older women or younger women with prematurely aging ovaries. They offer extensive, research-based treatment plans tailored to each patient, which have led to successful outcomes where other fertility centers have fallen short. In addition to infertility care, CHR operates an innovative egg donor program that prioritizes equality and transparency. Their program features a unique egg donor compensation structure and third-party insurance policy, ensuring fairness to both egg donors and recipients. Through its commitment to personalized care, innovative research, and patient-centric approach, CHR has established itself as a leader in the Health Care industry. Although specific details about CHR's recent investments and investors are not available, its longstanding success, expertise, and distinctive programs make it an intriguing prospect for potential venture capital investment. With an emphasis on cutting-edge research and a global reach, CHR presents an opportunity for investors to support a pioneering organization at the forefront of infertility care.